Hosted on MSN9mon
Senators demand answers from drugmaker about discontinuation of popular insulin Levemir
Last November, Novo Nordisk announced it would stop selling the injectable FlexPen version of Levemir ... include Sanofi's Lantus and Novo Nordisk's Tresiba. When Levemir is no longer available ...
pharmaphorum6y
Real-world diabetes study CONFIRMs positive comparative efficacy for Novo's Tresiba
Novo Nordisk presented the latest results for its diabetes injectable Tresiba last weekend. These demonstrated significantly better control of blood sugar levels than Sanofi’s Toujeo ...
pharmaphorum1d
Novo's Tresiba primed for key 'hypo' label update in EU
Novo Nordisk's long-acting insulin Tresiba is set to gain new hypoglycaemia prevention claims in Europe, giving it an advantage over Sanofi’s top-selling Lantus. Europe's CHMP committee has just ...